Skip to content
Baret News – Lifestyle
Author:
Biodexa Pharmaceuticals PLC
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
September 23, 2026
Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds
September 15, 2026
Interim results for the six months ended June 30, 2026
September 14, 2026
Result of General Meeting
July 29, 2026
Result of Annual General Meeting
June 30, 2026
Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants
June 30, 2026
Postponement and Re-scheduling of Annual General Meeting
June 17, 2026
Biodexa issues letter to Shareholders
May 21, 2026
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
April 2, 2026
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
March 23, 2026